Search Results - "Skee, D."

Canagliflozin improves glycaemic control over 28 days in subjects with type 2 diabetes not optimally controlled on insulin by Devineni, D., Morrow, L., Hompesch, M., Skee, D., Vandebosch, A., Murphy, J., Ways, K., Schwartz, S.

“…Aim: Canagliflozin is a sodium‐glucose co‐transporter 2 (SGLT2) inhibitor that is being investigated for the treatment of type 2 diabetes mellitus (T2DM)…”
Get full text

P779 Pharmacokinetics of ceftobiprole following single and multiple intravenous infusions administered to healthy subjects by Murthy, B, Skee, D, Wexler, D, Balis, D, Chang, I, Desai-Kreiger, D, Noel, G

Get full text

Multiple-dose pharmacokinetics of a contraceptive patch in healthy women participants by Abrams, Larry S., Skee, Donna M., Natarajan, Jaya, Wong, Frankie A., Lasseter, Kenneth C.

“…This open-label, randomized study evaluated the pharmacokinetics of norelgestromin (NGMN) and ethinyl estradiol (EE) following the application of a…”
Get full text

Pharmacokinetics of Norelgestromin and Ethinyl Estradiol from Two Consecutive Contraceptive Patches by Abrams, Larry S., Skee, Ms. Donna M., Wong, Frankie A., Anderson, Ms. Nika J., Leese, Philip T.

“…The primary objective of this open‐label study was to determine the pharmacokinetics of norelgestromin (NGMN) and ethinyl estradiol (EE) following two…”
Get full text

Pharmacokinetics (PK) of the pan-FGFR inhibitor erdafitinib in urothelial carcinoma by Tabernero, J., Infante, J.R., Mita, A., Keung, C., Skee, D., Xie, H., Parekh, T., De Porre, P., Luo, F.R., Soria, J.-C.

Get full text

Ferromagnetism in decamethylchromocenium tetracyanoethylenide : configuration mixing does not explain ferromagnetic spin coupling in metallocenium charge-transfer salts by EICHHORN, D. M, SKEE, D. C, BRODERICK, W. E, HOFFMAN, B. M

Get full text

Pharmacokinetic overview of Ortho Evra/Evra by Abrams, Larry S, Skee, Donna, Natarajan, Jaya, Wong, Frankie A

“…The pharmacokinetics of norelgestromin, the primary active metabolite of norgestimate, plus ethinyl estradiol (EE), delivered by the once-weekly contraceptive…”
Get more information

Pharmacokinetics and Pharmacodynamics of a Transdermal Contraceptive Patch and an Oral Contraceptive by Devineni, Damayanthi, Skee, Donna, Vaccaro, Nicole, Massarella, Joseph, Janssens, Luc, LaGuardia, Katherine D., Leung, Albert T.

“…This open‐label, randomized, 2‐way crossover study characterized the pharmacokinetics and pharmacodynamics of a transdermal contraceptive patch and a…”
Get full text

Determination of azarole plus its reduction product by HPLC by McCoy, L F, Skee, D M, Edelson, J

“…An analytical methodology for the assay of azarole plus its reduced product in plasma was developed. The method consists of oxidation of the sample with…”
Get more information

Pharmacokinetics of Norelgestromin and Ethinyl Estradiol Delivered by a Contraceptive Patch (Ortho Evra™/Evra™) under Conditions of Heat, Humidity, and Exercise by Abrams, Larry S., Skee, Ms. Donna M., Natarajan, Jaya, Wong, Frankie A., Leese, Philip T., Creasy, George W., Shangold, Mona M.

“…The objectives of this randomized, open‐label, three‐period, incomplete block design study were to evaluate the pharmacokinetics of norelgestromin (NGMN) and…”
Get full text

Determination of a novel steroidal androgen receptor antagonist (Win 49596) in human plasma using solid-phase extraction and high-performance liquid chromatography with ultraviolet detection by Skee, D M, Cook, J A, Benziger, D P

“…A rapid, sensitive and selective method was developed for the determination of a novel steroidal androgen receptor antagonist (Win 49596, I) in human plasma…”
Get more information

An overview of the pharmacokinetics of a contraceptive patch by Abrams, L.S., Skee, D., Natarajan, J., Wong, F.

Get full text

Pharmacokinetics of a contraceptive patch (Evra™/Ortho Evra™) containing norelgestromin and ethinyloestradiol at four application sites by Abrams, Larry S., Skee, Donna M., Natarajan, Jaya, Wong, Frankie A., Anderson, Gary D.

“…Aims  To determine the pharmacokinetic profile of norelgestromin (NGMN) and ethinyloestradiol (EE) following application of the contraceptive patch, Evra™/…”
Get full text

Pharmacokinetic model and simulations of dose conversion from immediate- to extended-release tramadol by Murthy, Bindu P., Skee, Donna M., Danyluk, Alexander P., Brett, Vincent, Vorsanger, Gary J., Moskovitz, Bruce L.

“…ABSTRACT Objective: Extended-release tramadol (tramadol ER) is a once-daily formulation of tramadol approved in the United States for moderate to moderately…”
Get full text

Pharmacokinetics and Pharmacodynamics of the Contraceptive Patch ORTHO EVRA and an OC (CILEST) by Leung, Albert, LaGuardia, Katherine D., Massarella, Joseph, Skee, Donna M., Janssens, Luc

Get full text

Determination of fezolamine and its desmethyl metabolite in human plasma and urine by high-performance liquid chromatography. Intravenous pharmacokinetics in the beagle hound by McCoy, L, Skee, D, Edelson, J

“…Sensitive and selective high-performance liquid chromatographic methods for the quantitation of the experimental antidepressant fezolamine and its desmethyl…”
Get more information